Management of Bilateral Pulmonary Infiltrates: Evidence‑Based Diagnostic and Therapeutic Strategies

Immediate Diagnostic Approach

In febrile or immunocompromised patients, start empiric antimicrobial therapy without delay while pursuing definitive diagnosis. 1
Presence of neutropenia, HIV/AIDS, or immunosuppressive therapy shifts the differential toward opportunistic infections and mandates immediate empiric antifungal coverage. [3][4]
Recent exposure to chemotherapy, immune‑checkpoint inhibitors, or drugs such as mesalazine can precipitate drug‑induced pneumonitis; a high index of suspicion is required. 5
A BNP > 100 pg/mL together with a CRP < 7 mg/dL favors cardiogenic pulmonary edema, whereas a CRP > 100 mg/L with a lower BNP points to infectious or inflammatory etiologies. 2
Neutropenia defined as an absolute neutrophil count < 500 cells/µL requires immediate broad‑spectrum antibacterial plus mold‑active antifungal therapy. [3][4]

Chest CT identifies infiltrates in 27–50 % of patients whose chest radiographs are nondiagnostic, providing essential pattern recognition. [3][4]2
Bilateral perihilar infiltrates with Kerley B lines and a “bat‑wing” appearance are characteristic of cardiogenic pulmonary edema. 2
Diffuse bilateral ground‑glass opacities with peripheral sparing strongly suggest Pneumocystis pneumonia in immunocompromised hosts. [3][4]
Nodular or cavitary peripheral lesions raise suspicion for septic emboli or invasive fungal infection. 3
The “halo sign” or “air‑crescent sign” on CT is highly indicative of invasive aspergillosis in neutropenic patients. [3][4]

Initiate mold‑active antifungal therapy (e.g., voriconazole or liposomal amphotericin B) immediately; pre‑emptive treatment improves survival. [3][4]
Continue broad‑spectrum antibacterial agents already started for febrile neutropenia. 3
Add high‑dose trimethoprim‑sulfamethoxazole (15–20 mg/kg/day of trimethoprim component) when CT shows diffuse ground‑glass opacities suggestive of Pneumocystis pneumonia. [3][4]
Perform urgent bronchoscopy with bronchoalveolar lavage for galactomannan, β‑D‑glucan, and microbiologic cultures; do not delay antifungal therapy while awaiting results. [3][4]
Provide unrestricted ICU support; favorable outcomes are reported even with respiratory failure when overall prognosis is not otherwise poor. [3][4]

Start empiric antibiotics targeting community‑acquired pneumonia (ceftriaxone + azithromycin or a respiratory fluoroquinolone). [1][2]
For pleural effusions ≥10 mm on lateral decubitus view, perform thoracentesis to differentiate parapneumonic effusion from empyema. 2
Re‑evaluate at 48–72 hours; if no clinical improvement, obtain a chest CT and consider bronchoscopy for further diagnostic clarification. [1][2]

Initiate diuresis promptly when BNP is elevated, bilateral perihilar infiltrates are present, and the patient has a history of cardiac disease or recent fluid overload. 2
Recognize that sepsis‑induced ARDS can produce permeability edema indistinguishable from cardiogenic edema on imaging; aggressive fluid resuscitation in septic patients may create a mixed picture. 2
Obtain urgent echocardiography to assess left‑ventricular function and guide therapy.

Discontinue the offending medication immediately when a temporal relationship with pneumonitis is identified. 5
Withhold immune‑checkpoint inhibitors for grade ≥ 2 pneumonitis (symptomatic with imaging changes). 5
Initiate systemic corticosteroids (prednisone 1–2 mg/kg/day or equivalent) for grade ≥ 2 pneumonitis, with a minimum taper of 4–6 weeks to prevent relapse. 5
Add infliximab or cyclophosphamide for steroid‑refractory cases. 5
Obtain pulmonology consultation and perform bronchoscopy with BAL to exclude infection before commencing immunosuppression. 5

Perform high‑resolution CT to characterize reticulonodular patterns and distribution. 6
Screen for connective‑tissue disease (ANA > 1:160, rheumatoid factor, anti‑CCP) when a bilateral basal reticular pattern is observed. 6
Evaluate occupational and environmental exposures (e.g., asbestos, bird or mold exposure) that may explain hypersensitivity pneumonitis or asbestosis. 6
If non‑invasive work‑up remains inconclusive, consider surgical lung biopsy to differentiate usual interstitial pneumonia (poor prognosis) from nonspecific interstitial pneumonia (corticosteroid‑responsive). [7][6]

A normal chest X‑ray does not exclude pneumonia; CT can reveal infiltrates in up to 50 % of such cases. [3][2]
Do not postpone antifungal therapy in neutropenic patients awaiting microbiologic confirmation; early mold‑active treatment is associated with improved survival. [3][4]
Avoid rapid corticosteroid taper (< 4 weeks) in drug‑induced pneumonitis, as premature tapering commonly leads to recrudescence. 5
Bilateral infiltrates are not always infectious; drug toxicity, pulmonary edema, and organizing pneumonia are frequent mimics requiring distinct management strategies. [1][2]
Pneumonia and pulmonary edema often coexist in critically ill patients; sepsis‑induced ARDS combined with aggressive fluid resuscitation creates a mixed picture that necessitates treatment of both pathologies. 2